Inferring Sequential Order of Somatic Mutations during Tumorgenesis based on Markov Chain Model
- PMID: 26451822
- DOI: 10.1109/TCBB.2015.2424408
Inferring Sequential Order of Somatic Mutations during Tumorgenesis based on Markov Chain Model
Abstract
Tumors are developed and worsen with the accumulated mutations on DNA sequences during tumorigenesis. Identifying the temporal order of gene mutations in cancer initiation and development is a challenging topic. It not only provides a new insight into the study of tumorigenesis at the level of genome sequences but also is an effective tool for early diagnosis of tumors and preventive medicine. In this paper, we develop a novel method to accurately estimate the sequential order of gene mutations during tumorigenesis from genome sequencing data based on Markov chain model as TOMC (Temporal Order based on Markov Chain), and also provide a new criterion to further infer the order of samples or patients, which can characterize the severity or stage of the disease. We applied our method to the analysis of tumors based on several high-throughput datasets. Specifically, first, we revealed that tumor suppressor genes (TSG) tend to be mutated ahead of oncogenes, which are considered as important events for key functional loss and gain during tumorigenesis. Second, the comparisons of various methods demonstrated that our approach has clear advantages over the existing methods due to the consideration on the effect of mutation dependence among genes, such as co-mutation. Third and most important, our method is able to deduce the ordinal sequence of patients or samples to quantitatively characterize their severity of tumors. Therefore, our work provides a new way to quantitatively understand the development and progression of tumorigenesis based on high throughput sequencing data.
Similar articles
-
A novel framework for analyzing somatic copy number aberrations and tumor subclones for paired heterogeneous tumor samples.Biomed Mater Eng. 2015;26 Suppl 1:S1845-53. doi: 10.3233/BME-151487. Biomed Mater Eng. 2015. PMID: 26405956
-
Deciphering oncogenic drivers: from single genes to integrated pathways.Brief Bioinform. 2015 May;16(3):413-28. doi: 10.1093/bib/bbu039. Epub 2014 Nov 5. Brief Bioinform. 2015. PMID: 25378434 Review.
-
High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing.Clin Cancer Res. 2014 Apr 15;20(8):2080-91. doi: 10.1158/1078-0432.CCR-13-3114. Epub 2014 Feb 26. Clin Cancer Res. 2014. PMID: 24573554
-
A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis.BMC Bioinformatics. 2019 Dec 2;20(1):620. doi: 10.1186/s12859-019-3218-2. BMC Bioinformatics. 2019. PMID: 31791231 Free PMC article.
-
Fundamentals of pyrosequencing.Arch Pathol Lab Med. 2013 Sep;137(9):1296-303. doi: 10.5858/arpa.2012-0463-RA. Arch Pathol Lab Med. 2013. PMID: 23991743 Review.
Cited by
-
Progression inference for somatic mutations in cancer.Heliyon. 2017 Apr 11;3(4):e00277. doi: 10.1016/j.heliyon.2017.e00277. eCollection 2017 Apr. Heliyon. 2017. PMID: 28492066 Free PMC article.
-
Effects of ordered mutations on dynamics in signaling networks.BMC Med Genomics. 2020 Feb 20;13(Suppl 4):13. doi: 10.1186/s12920-019-0651-z. BMC Med Genomics. 2020. PMID: 32075651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous